Effects of zinc and DHA on the epigenetic regulation of human neuronal cells

Cellular Physiology and Biochemistry

Volumn 29, Issue 1-2, 2012, Pages 87-98

  Sadli, Nadia ^a   Ackland, M Leigh ^a   De Mel, Damitha ^a   Sinclair, Andrew J ^a   Suphioglu, Cenk ^a  

^a DEAKIN UNIVERSITY   (Australia)

Author keywords

DHA; Epigenetics; Histone H3 post translational modification; M17 human neuronal cell; Omega 3 fatty acid; Zinc

Indexed keywords

BETA ACTIN; BIOLOGICAL MARKER; DOCOSAHEXAENOIC ACID; HISTONE DEACETYLASE 1; HISTONE H3; HISTONE H4; OMEGA 3 FATTY ACID; PROTEIN BCL 2; ZINC;

APOPTOSIS; ARTICLE; CELL VIABILITY; CONTROLLED STUDY; DEACETYLATION; DEGENERATIVE DISEASE; DENSITOMETRY; DIETARY INTAKE; EPIGENETICS; GENE CONTROL; HUMAN; HUMAN CELL; IMMUNOBLOTTING; METHYLATION; NERVE CELL; NEUROPROTECTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING;

EID: 84859873820     PISSN: 10158987     EISSN: 14219778     Source Type: Journal    
DOI: 10.1159/000337590     Document Type: Article

References (59)

1. Johnson EJ, Schaefer EJ: Potential role of dietary n-3 fatty acids in the prevention of dementia and macular degeneration. Am J Clin Nutr 2006;83:1494S-1498S. (Pubitemid 44713090)
2. Schaefer EJ, Bongard V, Beiser AS: Plasma phosphatidylcholine docosahexaenoic acid content and risk of dementia and Alzheimer disease: the Framingham Heart Study. Arch Neurol 2006;63:1545-1550. (Pubitemid 44748796)
3. Moriguchi T, Greiner RS, Salem N: Behavioral deficits associated with dietary induction of decreased brain docosahexaenoic acid concentration. J Neurochem 2000;75:2563-2573.
4. Friedland RP: Fish consumption and the risk of Alzheimer disease: is it time to make dietary recommendations? Arch Neurol 2003;60:923-924. (Pubitemid 36858349)
5. Cunnane SC, Yang J: Zinc deficiency impairs whole-body accumulation of polyunsaturates and increases the utilization of [1-14C]linoleate for de novo lipid synthesis in pregnant rats. Can J Physiol Pharmacol 1995;73:1246-1252. (Pubitemid 26024203)
6. Jayasooriya AP, Ackland ML, Mathai ML, Sinclair AJ, Weisinger HS, Weisinger RS, Halver JE, Kitajka K, Puskás LG: Perinatal omega-3 polyunsaturated fatty acid supply modifies brain zinc homeostasis during adulthood. Proc Natl Acad Sci USA 2005;102:713-718.
7. Lee JY, Cole TB, Palmiter RD, Suh SW, Koh JY: Contribution by synaptic zinc to the gender-disparate plaque formation in human Swedish mutant APP transgenic mice. Proc Natl Acad Sci USA 2002;99:7705-7710. (Pubitemid 34568755)
8. Naganska E, Matyja E: Apoptotic neuronal changes enhanced by zinc chelator-TPEN in organotypic rat hippocampal cultures exposed to anoxia. Folia Neuropathol 2006;44:125-132. (Pubitemid 44083243)
9. Calon F, Lim GP, Yang F, Morihara T, Teter B, Ubeda O, Rostaing P, Triller A, Salem N Jr, Ashe KH, Frautschy SA, Cole GM: Docosahexaenoic acid protects from dendritic pathology in an Alzheimer's disease mouse model. Neuron 2004;43:633-645. (Pubitemid 39179724)
10. Oksman M, Iivonen H, Hogyes E, Amtul Z, Penke B, Leenders I, Broersen L, Lütjohann D, Hartmann T, Tanila H: Impact of different saturated fatty acid, polyunsaturated fatty acid and cholesterol containing diets on beta-amyloid accumulation in APP/PS1 transgenic mice. Neurobiol Dis 2006;23:563-572. (Pubitemid 44234092)
11. Florent-Béchard S, Malaplate-Armand C, Koziel V, Kriem B, Olivier JL, Pillot T, Oster T: Towards a nutritional approach for prevention of Alzheimer's disease: biochemical and cellular aspects. J Neurol Sci 2007;262:27-36. (Pubitemid 47398892)
12. Akbar M, Calderon F, Wen Z, Kim HY: Docosahexaenoic acid: a positive modulator of Akt signalling in neuronal survival. Proc Natl Acad Sci USA 2005;102:10858-10863. (Pubitemid 41105957)
13. Kim YM, Chung HT, Simmons RL, Billiar TR: Cellular non-heme iron content is a determinant of nitric oxide-mediated apoptosis, necrosis, and caspase inhibition. J Biol Chem 2000;275:10954-10961. (Pubitemid 30212732)
14. Suphioglu C, Sadli N, Coonan D, Kumar L, De Mel D, Lesheim J, Sinclair AJ, Ackland L: Zinc and DHA have opposing effects on the expression levels of histones H3 and H4 in human neuronal cells. Brit J Nutr 2010;103:344-351.
15. Ausio J, Don, F, van Holde KE: Use of selectively trypsinized nucleosome core particles to analyze the role of the histone "tails" in the stabilization of the nucleosome. J Mol Biol 1989;206:451-463. (Pubitemid 19104985)
16. Bernstein E, Allis CD: RNA meets chromatin. Genes Dev 2005;19:1635-1655. (Pubitemid 41058358)
17. Sugars KL, Rubinsztein DC: Transcriptional abnormalities in Huntington disease. Trends Genet 2003;19:233-238. (Pubitemid 36511427)
18. Cha JH: Transcriptional signatures in Huntington's disease. Prog Neurobiol 2007;83:228-248.
19. Wang CM, Tsai SN, Yew TW, Kwan YW, Ngai SM: Identification of histone methylation multiplicities patterns in the brain of senescence-accelerated prone mouse 8. Biogerontology 2010;11:87-102.
20. Saha RN, Pahan K: HATs and HDACs in neurodegeneration: a tale of disconcerted acetylation homeostasis. Cell Death Differ 2006:13:539-550.
21. Vannini A, Volpari C, Filocamo G, Casavola EC, Brunetti M, Renzoni D, Chakravarty P, Paolini C, De Francesco R, Gallinari P, Steinkühler C, Di Marco S: Crystal structure of a eukaryotic zincdependent histone deacetylase, human HDAC8, complexed with a hydroxamic acid inhibitor. Proc Natl Acad Sci USA 2004;101:15064-15069. (Pubitemid 39391719)
22. Ficner R: Novel structural insights into class I and II histone deacetylases. Curr Top Med Chem 2009;9:235-240.
23. Marks PA, Richon VM, Rifkind RA: Histone deacetylase inhibitors: inducers of differentiation or apoptosis of transformed cells. J Natl Cancer Inst 2000;92:1210-1216. (Pubitemid 30627729)
24. Butler R, Bates GP: Histone deacetylase inhibitors as therapeutics for polyglutamine disorders. Nat Rev Neurosci 2006;7:784-796. (Pubitemid 44435261)
25. Rapoport SI: In vivo approaches to quantifying and imaging brain arachidonic and docosahexaenoic acid metabolism. J Pediatr 2003;143:S26-34. (Pubitemid 37346691)
26. Freeland K, Boxer LM, Latchman DS: The cyclic AMP response element in the Bcl-2 promoter confers inducibility by hypoxia in neuronal cells. Brain Res Mol Brain Res 2011;92:98-106.
27. Ding WQ, Liu B, Vaught JL, Palmiter RD, Lind SE: Clioquinol and docosahexaenoic acid act synergistically to kill tumor cells. Mol Cancer Ther 2006;5:1864-1872. (Pubitemid 44323255)
28. Chuikov S, Kurash JK, Wilson JR, Xiao B, Justin N, Ivanov GS, McKinney K, Tempst P, Prives C, Gamblin SJ, Barlev NA, Reinberg D: Regulation of p53 activity through lysine methylation. Nature 2004;432:353-360. (Pubitemid 39551664)
29. Al-Gazali LI, Padmanabhan R, Melnyk S, Yi P, Pogribny IP, Pogribny M, Bakir M, Hamid ZA, Abdulrazzaq Y, Dawodu A, James SJ: Abnormal folate metabolism and genetic polymorphism of the folate pathway in a child with Down syndrome and neural tube defect. Am J Med Genet 2001;103:128-132.
30. Wainfan E, Poirier LA: Methyl groups in carcinogenesis: effects on DNA methylation and gene expression. Cancer Res 1992;52:2071s-2077s.
31. Pogribny IP, Basnakian AG, Miller BJ, Lopatina NG, Poirier LA, James SJ: Breaks in genomic DNA and within the p53 gene are associated with hypomethylation in livers of folate/ methyl-deficient rats. Cancer Res 1995;55:1894-1901.
32. Berger SL: The complex language of chromatin regulation during transcription. Nature 2007;447:407-412. (Pubitemid 46816746)
33. Strahl BD, Ohba R, Cook RG, Allis CD: Methylation of histone H3 at lysine 4 is highly conserved and correlates with transcriptionally active nuclei in Tetrahymena. Proc Natl Acad Sci USA 1999;96:14967-14972. (Pubitemid 30019748)
34. Kouzarides T: Chromatin modifications and their function. Cell 2007;128:693-705. (Pubitemid 46273577)
35. Xiao B, Wilson JR, Gamblin SJ: SET domains and histone methylation. Curr Opin Struct Biol 2003;13:699-705. (Pubitemid 37522145)
36. Li J, Lin Q, Yoon HG, Huang ZQ, Strahl BD, Allis CD, Wong J: Involvement of histone methylation and phosphorylation in regulation of transcription by thyroid hormone receptor. Mol Cell Biol 2002;22:5688-5697. (Pubitemid 34815819)
37. Hampsey M, Reinberg D: Tails of intrigue: phosphorylation of RNA polymerase II mediates histone methylation. Cell 2003;113:429-432. (Pubitemid 36588746)
38. Kizer KO, Phatnani HP, Shibata Y, Hall H, Greenleaf AL, Strahl BD: A novel domain in Set2 mediates RNA polymerase II interaction and couples histone H3 K36 methylation with transcript elongation. Mol Cell Biol 2005;25:3305-3316. (Pubitemid 40464330)
39. Li J, Moazed D, Gygi SP: Association of the histone methyltransferase Set2 with RNA polymerase II plays a role in transcription elongation. J Biol Chem 2002;277:49383-49388. (Pubitemid 36014370)
40. Game JC, Williamson MS, Baccari C: Xray survival characteristics and genetic analysis for nine Saccharomyces deletion mutants that show altered radiation sensitivity. Genetics 2005;169:51-63. (Pubitemid 40239153)
41. Huyen Y, Zgheib O, Ditullio RA Jr, Gorgoulis VG, Zacharatos P, Petty T, Sheston EA, Mellert HS, Stavridi ES, Halazonetis TD: Methylated lysine 79 of histone H3 targets 53BP1 to DNA double-strand breaks. Nature 2004;432:406-411. (Pubitemid 39551676)
42. Rhodes LE, Shahbakhti H, Azurdia RM, Moison RM, Steenwinkel MJ, Homburg MI, Dean MP, McArdle F, Beijersbergen van Henegouwen GM, Epe B, Vink AA: Effect of eicosapentaenoic acid, an omega-3 polyunsaturated fatty acid, on UVR-related cancer risk in humans. An assessment of early genotoxic markers. Carcinogenesis 2003;24:919-925. (Pubitemid 36748909)
43. Fischle W, Wang Y, Allis CD: Binary switches and modification cassettes in histone biology and beyond. Nature 2003;425:475-479. (Pubitemid 37237036)
44. Eissenberg JC, Elgin SC: Molecular biology: antagonizing the neighbours. Nature 2005;438:1090-1.
45. German OL, Insua MF, Gentili C, Rotstein NP, Politi LE: Docosahexaenoic acid prevents apoptosis of retina photoreceptors by activating the ERK/ MAPK pathway. J Neurochem 2006;98:1507-1520. (Pubitemid 44200442)
46. Akbar M, Baick J, Calderon F, Wen Z, Kim HY: Ethanol promotes neuronal apoptosis by inhibiting phosphatidylserine accumulation. J Neurosci Res 2006;83:432-440. (Pubitemid 43184406)
47. Edelstein LC, Pan A, Collins T: Chromatin modification and the endothelial-specific activation of the Eselectin gene. J Biol Chem 2005;280:11192-11202. (Pubitemid 40418426)
48. Guan JS, Haggarty SJ, Giacometti E, Dannenberg JH, Joseph N, Gao J, Nieland TJ, Zhou Y, Wang X, Mazitschek R, Bradner JE, DePinho RA, Jaenisch R, Tsai LH: HDAC2 negatively regulates memory formation and synaptic plasticity. Nature 2009;459:55-60.
49. Kuzmichev A, Nishioka K, Erdjument-Bromage H, Tempst P, Reinberg D: Histone methyltransferase activity associated with a human multiprotein complex containing the Enhancer of Zeste protein. Genes Dev 2002;16:2893-2905. (Pubitemid 35334738)
50. Soppe WJ, Jasencakova Z, Houben A, Kakutani T, Meister A, Huang MS, Jacobsen SE, Schubert I, Fransz PF: DNA methylation controls histone H3 lysine 9 methylation and heterochromatin assembly in Arabidopsis. EMBO J 2002;21:6549-6559. (Pubitemid 35448432)
51. Watanabe H, Soejima K, Yasuda H, Kawada I, Nakachi I, Yoda S, Naoki K, Ishizaka A: Deregulation of histone lysine methyltransferases contributes to oncogenic transformation of human bronchoepithelial cells. Cancer Cell Int 2008;8:15.
52. Kim SY, Lee JH, Yang ES, Kil IS, Park JW: Human sensitive to apoptosis gene protein inhibits peroxynitrite-induced DNA damage. Biochem Biophys Res Commun 2003;301:671-674. (Pubitemid 36268943)
53. Yu J, Zhang L, Hwang PM, Rago C, Kinzler KW, Vogelstein B: Identification and classification of p53-regulated genes. Proc Natl Acad Sci USA 1999;96:14517-14522. (Pubitemid 30000682)
54. DiTullio,RA Jr, Mochan TA, Venere M, Bartkova J, Sehested M, Bartek J, Halazonetis TD: 53BP1 functions in an ATM-dependent checkpoint pathway that is constitutively activated in human cancer. Nat Cell Biol 2002;4:998-1002. (Pubitemid 35469432)
55. Dai J, Sultan S, Taylor SS, Higgins JM: The kinase haspin is required for mitotic histone H3 Thr 3 phosphorylation and normal metaphase chromosome alignment. Genes Dev 2005;19:472-488. (Pubitemid 40256279)
56. Im H, Park C, Feng Q, Johnson KD, Kiekhaefer CM, Choi K, Zhang Y, Bresnick EH: Dynamic regulation of histone H3 methylated at lysine 79 within a tissue-specific chromatin domain. J Biol Chem 2003;278:18346-18352. (Pubitemid 36799455)
57. Sawado T, Halow J, Im H, Ragoczy T, Bresnick EH, Bender MA, Groudine M: H3 K79 dimethylation marks developmental activation of the beta-globin gene but is reduced upon LCR-mediated highlevel transcription. Blood 2008;112:406-414.
58. Khan AA, Mao XO, Banwait S, Jin K, Greenberg DA: Neuroglobin attenuates beta-amyloid neurotoxicity in vitro and transgenic Alzheimer phenotype in vivo. Proc Natl Acad Sci USA 2007;104:19114-19119.
59. Sankaranarayanan S, Price EA, Wu G, Crouthamel MC, Shi XP, Tugusheva K, Tyler KX, Kahana J, Ellis J, Jin L, Steele T, Stachel S, Coburn C, Simon AJ: In vivo beta-secretase 1 inhibition leads to brain Abeta lowering and increased alphasecretase processing of amyloid precursor protein without effect on neuregulin-1. J Pharmacol Exp Ther 2008;324:957-969. (Pubitemid 351397853)